These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2820358)

  • 1. Steroid therapy in multiple sclerosis. Point of view.
    Troiano R; Cook SD; Dowling PC
    Arch Neurol; 1987 Aug; 44(8):803-7. PubMed ID: 2820358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic indications for acute episodes of multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):988-95. PubMed ID: 11787365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids in the treatment of multiple sclerosis.
    Myhr KM; Mellgren SI
    Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steroid therapy in multiple sclerosis].
    Beer S; Kesselring J
    Schweiz Med Wochenschr; 1991 Jun; 121(26):961-9. PubMed ID: 1650496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
    Tremlett HL; Luscombe DK; Wiles CM
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of multiple sclerosis].
    Arasa F
    Folia Clin Int (Barc); 1969 Jan; 19(1):7-23. PubMed ID: 4308450
    [No Abstract]   [Full Text] [Related]  

  • 7. Is steroid therapy in multiple sclerosis superior to corticotropin therapy?
    Davis FA; Stefoski D
    Arch Neurol; 1988 Nov; 45(11):1180. PubMed ID: 2847693
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive treatment of multiple sclerosis.
    Carter JL; Rodriguez M
    Mayo Clin Proc; 1989 Jun; 64(6):664-9. PubMed ID: 2473360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current methods of therapy in multiple sclerosis.
    Sibley WA
    Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of ACTH therapy on IgG synthesis in cerebrospinal fluid spaces in patients with disseminated sclerosis].
    Wender M; Michałowska G; Wajgt A
    Neurol Neurochir Pol; 1986; 20(5):437-43. PubMed ID: 3035406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group.
    Beck RW
    Neurology; 1992 Jun; 42(6):1133-5. PubMed ID: 1318520
    [No Abstract]   [Full Text] [Related]  

  • 12. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
    Brunner NG; Berger CL; Namba T; Grob D
    Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis.
    Troiano R; Hafstein M; Ruderman M; Dowling P; Cook S
    Ann Neurol; 1984 Mar; 15(3):257-63. PubMed ID: 6721447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotachophoresis quantitation of subfractions of multiple sclerosis intra-blood-brain barrier IgG synthesis modulated by ACTH and/or steroids.
    Tourtellotte WW; Potvin AR; Ma BI; Baumhefner RW; Walsh MJ; Dickstein P; Ingram T; Cowan T; Shapshak P; Delmotte P
    Neurology; 1982 Mar; 32(3):261-6. PubMed ID: 6278361
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple sclerosis: current diagnostic and therapeutic data].
    Schoenen J; Burton L; Figiel C; Delwaide PJ
    Rev Med Liege; 1979 Mar; 34(5):145-53. PubMed ID: 219459
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course and corticosteroid therapy of multiple sclerosis among Japanese patients].
    Kira JI; Itoyama Y; Tabira T; Tobimatsu S; Shibasaki H; Kuroiwa Y
    Rinsho Shinkeigaku; 1983 Aug; 23(8):646-54. PubMed ID: 6319063
    [No Abstract]   [Full Text] [Related]  

  • 18. [IgG synthesis in the cerebrospinal fluid in patients with the chronic progressive phase of multiple sclerosis treated with cyclophosphamide and ACTH].
    Wender M; Michałowska G
    Neurol Neurochir Pol; 1986; 20(6):536-41. PubMed ID: 3037408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1975; 10(3):166-210. PubMed ID: 172309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The behavior of serum immunoglobulins in multiple sclerosis during anti-inflammatory therapy].
    Paltrinieri E; Giovannucci M
    Acta Neurol (Napoli); 1969; 24(4):613-25. PubMed ID: 4101181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.